Rilonacept in Subjects with Cardiac Sarcoidosis

Rilonacept in Subjects with Cardiac Sarcoidosis

Status: Recruiting

Conditions: Myocarditis, Sarcoidosis

Location:

Johns Hopkins University
Mayo Clinic in Rochester

City/State:

Baltimore, Maryland


Rochester, Minnesota

Contact Information:

Lezlie Peterson, R.N.
Phone Number: 507-255-2029
Email: [email protected]

Brief Summary: The primary objective of this study is to evaluate the effect of rilonacept, added to standard therapy and compared with standard therapy alone, on improvement in myocardial inflammation in subjects with cardiac sarcoidosis after 24 weeks of therapy.

 

Contact Us

Contact Us

(281) 713-2962
800 Rockmead Drive, Suite 155
Kingwood, TX 77339
[email protected]

Social Media

Donations

Help Us End Suffering and Sudden Death from Myocarditis!

Donate to the Myocarditis Foundation Today!